LTR Pharma

LTR Pharma has executed a definitive Telehealth Distribution Agreement with Shed Holdings LLC, a leading U.S. direct-to-consumer telehealth platform, converting the previously announced binding Term Sheet into a definitive commercial agreement governing the planned U.S. commercialisation of ROXUS®. The agreement establishes the commercial framework for the planned U.S. commercialisation of ROXUS. Shed will commercialise

LTR Pharma has signed a term sheet with Strive Specialties, a United States personalised medicine and 503A pharmacy for ROXUS®.   This establishes the pharmacy fulfilment infrastructure required to supply ROXUS in the US and follows our announcement earlier this week that Shed Holdings, a direct-to-consumer (DTC) telehealth platform, will be a US distributor for

News update: Leading Australian medical experts are driving public awareness and conversation about the increased severity and prevalence of sexual issues in men aged 65+, with a focus on Erectile Dysfunction (ED). Men in their 40’s have about a 40% chance of experiencing some form of ED, with prevalence increasing